In this episode of Yet Another Value Podcast, host Andrew Walker shares a keynote Q&A from the Showcase Vegas event with returning guest Artem Fokin of Caro-Kann Capital. Artem breaks down his concept of “superpowers” in investing—an individual’s unique edge based on comparative advantage—and how it shapes portfolio decisions. The discussion extends into sell discipline, including identifying when a thesis is broken and handling emotional pitfalls during drawdowns. Artem also touches on evaluating management teams, international microcap investing, and the psychological toll of investing for a living. The conversation is a practical dive into staying grounded and focused amid the volatility of markets.

______________________________________________________________________

[0:00:00] Intro & sponsor message.

[0:02:45] Andrew introduces Artem.

[0:03:45] Defining investment 'superpower'.

[0:05:08] Artem's investing superpower explained.

[0:06:30] Identifying others' superpowers.

[0:08:15] Matching skills to stock selection.

[0:09:30] Using expert calls effectively.

[0:10:55] Selling stocks on thesis change.

[0:13:46] Holding through macro noise.

[0:15:12] Assessing management capability.

[0:17:30] Micro vs. large cap dynamics.

[0:19:30] International vs. US investing.

[0:23:10] Mental resilience in investing.

[0:26:00] Avoiding emotional decision-making.

[0:30:00] Balancing fund and personal finance.

[0:33:00] Final thoughts and close.

Links:

Yet Another Value Blog - https://www.yetanothervalueblog.com

See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer

In this episode of Yet Another Value Podcast, host Andrew Walker interviews the first-year Columbia MBA team who unanimously won the 18th Annual Pershing Square Challenge with their investment thesis on Carlisle Companies (CSL). The team—Tuan, Dimitry, and Erik—shares their detailed research into the commercial roofing giant, exploring its competitive moats, sticky customer relationships, management alignment, valuation framework, and opportunities for expansion. They discuss their firsthand trade show research, unique insight into labor dynamics, and responses to key concerns like cyclicality and pricing power. The conversation also covers the company's history, recent transformation, and what could keep an investor up at night.

You can find the team's CSL pitch deck here: https://www.dropbox.com/scl/fi/mn4ib4897o8gfpgdzs03c/CSL-US-Carlisle-Pershing-Square-Challenge-Presentation_YAVB_Abridged.pdf?rlkey=ck47pu6samrrnctwlfyr536hc&e=1&st=nj9zt415&dl=0_

_____________________________________________________________________

[00:00:00] Intro to podcast and guests

[00:02:44] Guest introductions and backgrounds

[00:05:35] Overview of Carlisle Companies

[00:08:32] Pitch background and idea process

[00:13:03] Unique research: trade show visits

[00:19:28] Carlisle’s competitive advantages

[00:24:58] Sticky customer and contractor base

[00:30:00] Valuation and IRR framework

[00:35:14] Management's strategy and alignment

[00:42:07] Target 2030 growth breakdown

[00:46:20] QXO, Beacon, and distribution impact

[00:52:22] Risks and margin sustainability

[00:54:28] Potential new entrants: Berkshire risk

[00:56:33] Labor shortages and benefits

[01:00:17] Leverage and capital allocation debate

[01:02:56] Final reflections and thank yous

Links:

Yet Another Value Blog - https://www.yetanothervalueblog.com See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer

In this May 2025 edition of Yet Another Value Podcast, host Andrew Walker shares a range of thoughts in his monthly solo ramble. He opens with macro commentary on market resilience post-"Liberation Day" and ongoing CEO uncertainty. He transitions to the role of AI in investing, using analogies from sports to explore how AI may alter investor success profiles. Andrew dives into how management teams' sales skills can mislead investors and shares his growing skepticism from biotech engagements. The episode closes with reflections on how personal preferences influence investing decisions and a detailed breakdown of how sunk costs and overhead can erode biotech value.

______________________________________________________________________

[0:00:00] Podcast intro and episode preview.

[0:02:02] Corporate governance discussion overview.

[0:03:22] Host introduction and podcast growth.

[0:04:16] Topics: market, AI, management, products.

[0:05:09] Market reaction since Liberation Day.

[0:07:26] CEO uncertainty and delayed investments.

[0:11:44] Complacency, speculative vs. cyclical sectors.

[0:12:22] AI as knowledge enhancer for investors.

[0:14:01] AI and sports analogies for change.

[0:18:46] AI impacting future investor skillsets.

[0:22:05] Management interviews and AI impact.

[0:25:24] Trusting vs. over-trusting management teams.

[0:31:44] Selling skills of management vs. investors

[0:34:09] Viral products and parsing endorsements.

[0:38:32] Disliking a product but buying stock.

[0:42:20] Balancing personal preferences with investing.

[0:44:00] Management and sunk costs in biotech.

[0:53:44] Overhead expenses distort trial economics.

[0:57:27] Wrap-up: biotech, books, and future episodes.

Links:

Yet Another Value Blog - https://www.yetanothervalueblog.com See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer